In the pharmaceutical industry, robotics are catalyzing innovation and efficiency across various domains. Recent patents highlight advancements such as improved cell culture handling and innovative cryoprotectant solutions. However, despite a decline in deals, the surge in job postings underscores the growing importance of robotics in pharmaceutical operations and research. The impact of robotics extends beyond the pharmaceutical sector, influencing various industries. GlobalData’s robotics in healthcare report provides comprehensive analysis of the market. Buy the report here.
Smarter leaders trust GlobalData
This article presents a quarterly round-up of the latest trends in the pharmaceutical industry regarding robotics. It provides an overview of recent developments in robotics-related deals, talent acquisition, and patent filings within the pharmaceutical industry.
Diverse applications of robotics in pharmaceutical industry
Pharma companies like Aixtron SE, X-Therma Inc, and Thrive Bioscience Inc are leveraging new robotics technologies through their latest patents. These technologies include methods for handling biological cell cultures, novel peptoid polymers for cryoprotectant solutions, and cell culture incubators with integrated manipulation systems. By acquiring these patents, Pharma companies can benefit from improved efficiency, accuracy, and automation in their research and production processes. These advancements in robotics will enable them to enhance the quality of their products, develop innovative solutions for preserving tissues and organs, and streamline their operations. Overall, these patents signify a significant step towards leveraging robotics in the Pharma industry for better outcomes and advancements in healthcare.
The industry remained flat in the number of robotics-related patent applications in Q1 2024 compared with the previous quarter. On an annual basis, the number of robotics-related patent applications in the pharmaceutical industry witnessed a drop of 10% compared with Q1 2023.
Strategic deal trends in robotics in pharmaceutical industry
Pharmaceutical companies are not only focusing on innovation to enhance their patent portfolios but are also making strategic investments in robotics. These investments aim to secure lucrative deals with partners and position themselves at the forefront of industry advancements. Some of the recent deals underscore the importance of robotics in the pharmaceutical industry.
In Q1 2024, the number of robotics-related deals in the pharmaceutical industry declined by 56% compared with Q1 2023. On a quarterly basis, there was 56% drop in the number of deals in Q1 2024 compared with the previous quarter.
Impact on hiring
In terms of new job posting, in Q1 2024, the pharmaceutical industry experienced a 33% growth compared with the previous quarter. On an annual basis, job postings also declined by 5%. Notably, management occupations, with a share of 16%, emerged as the top robotics-related job roles within the pharmaceutical industry in Q1 2024, with new job postings rising by 88% quarter-on-quarter. Architecture and engineering occupations came in second with a share of 15% in Q1 2024, with new job postings rising by 111% over the previous quarter. The other prominent robotics roles include life, physical, and social science occupations with a 14% share in Q1 2024, and computer and mathematical occupations with a 10% share of new job postings.
Johnson & Johnson, Takeda Pharmaceutical, AstraZeneca, Aurora Cannabis, and Eurofins Scientific are among the top companies leading in robotics hiring within the pharmaceutical industry.
Countries driving adoption of robotics in pharmaceutical industry
The US is the leading country in robotics adoption within the pharmaceutical industry, boasting the highest number of robotics-related patents, jobs, and deals. Meanwhile, South Korea, Italy, Denmark and Switzerland also maintain significant positions in robotics adoption within the pharmaceutical industry.
In conclusion, robotics are driving transformative changes in the pharmaceutical sector, offering enhanced efficiency and precision. Despite a decline in deals, the uptick in job postings signals a growing demand for robotics expertise in pharmaceutical research and development.
To further understand GlobalData's analysis on robotics in the pharmaceutical industry, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData patent analytics tracks patent filings and grants across companies and themes. Proprietary databases on deals and job analytics are used to respectively monitor global deal activity and uncover insights from daily job postings to identify trends, company activities, and industry dynamics across different sectors globally.
